A detailed history of Assetmark, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 15 shares of CRL stock, worth $2,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 6 150.0%
Holding current value
$2,976
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $1,857 - $2,418
9 Added 150.0%
15 $3,000
Q1 2024

May 06, 2024

BUY
$203.52 - $273.43 $1,221 - $1,640
6 New
6 $1,000
Q1 2023

May 05, 2023

SELL
$191.89 - $259.92 $575 - $779
-3 Reduced 18.75%
13 $2,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $16,863 - $23,899
-66 Reduced 80.49%
16 $5,000
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $5,270 - $6,730
15 Added 22.39%
82 $31,000
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $17,061 - $21,555
58 Added 644.44%
67 $25,000
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $86,635 - $103,919
-347 Reduced 97.47%
9 $3,000
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $38,406 - $43,703
173 Added 94.54%
356 $89,000
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $22,296 - $28,759
127 Added 226.79%
183 $41,000
Q2 2020

Aug 11, 2020

SELL
$118.84 - $189.72 $26,857 - $42,876
-226 Reduced 80.14%
56 $10,000
Q1 2020

May 12, 2020

BUY
$98.9 - $178.34 $15,626 - $28,177
158 Added 127.42%
282 $36,000
Q4 2019

Feb 11, 2020

BUY
$126.05 - $152.76 $15,252 - $18,483
121 Added 4033.33%
124 $19,000
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $875 - $1,005
-7 Reduced 70.0%
3 $0
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1,234 - $1,485
10 New
10 $1,000
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $419 - $586
-4 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $315 - $411
-3 Reduced 42.86%
4 $0
Q4 2015

Sep 15, 2017

BUY
N/A
7
7 $1,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.